News
UNCY
4.640
-1.17%
-0.055
Unicycive Faces New Securities Class Action Over NDA Disclosures
TipRanks · 4h ago
Unicycive Says Suit Alleges Securities Law Violations Over Statements On Oxylanthanum Carbonate FDA Application
Benzinga · 5h ago
Unicycive Therapeutics Discloses Securities Class Action Filed September 3 Against Company And Certain Officers
Benzinga · 5h ago
Weekly Report: what happened at UNCY last week (0921-0925)?
Weekly Report · 16h ago
Unicycive Therapeutics (UNCY) Gets a Buy from H.C. Wainwright
TipRanks · 09/21 17:57
Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback
TipRanks · 09/21 10:01
Weekly Report: what happened at UNCY last week (0914-0918)?
Weekly Report · 09/21 09:34
Robbins LLP Urges UNCY Stockholders Who Lost Money Investing in Unicycive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
Barchart · 09/18 16:46
Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback
TipRanks · 09/14 13:44
Weekly Report: what happened at UNCY last week (0907-0911)?
Weekly Report · 09/14 09:36
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 2, 2026 - UNCY
Barchart · 09/11 09:21
UNCY INVESTOR REMINDER: Unicycive Therapeutics, Inc. Investors Have Until November 2, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role
Barchart · 09/10 19:00
Law Offices of Frank R. Cruz Encourages Unicycive Therapeutics, Inc. (UNCY) Shareholders To Inquire About Securities Fraud Class Action
Barchart · 09/09 10:32
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
Barchart · 09/09 10:31
Deadline Approaching: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Barchart · 09/08 15:05
Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights
Barchart · 09/08 11:47
Deadline Soon: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Barchart · 09/07 11:15
Weekly Report: what happened at UNCY last week (0831-0904)?
Weekly Report · 09/07 09:33
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCY
Barchart · 09/07 06:30
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
Barchart · 09/05 12:18
More
Webull provides a variety of real-time UNCY stock news. You can receive the latest news about Unicycive Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About UNCY
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.